• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
PluriSIn 1

PluriSIn 1

Product ID P4782
Cas No. 91396-88-2
Purity ≥98%
Product Unit SizeCostQuantityStock
5 mg $68.10 In stock
10 mg $113.90 In stock
25 mg $235.40 In stock
50 mg $365.50 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

PluriSin 1 is a pluripotent cell-specific inhibitor that induces endoplasmic reticular stress and apoptosis in pluripotent stem cells. This compound inhibits stearoyl-coA desaturase 1 (SCD1), preventing teratoma formation in tumorigenic undifferentiated cells. Plurisin1 prevents undifferentiated cells from developing into tumors when used to regenerate tissues such as the heart.

Product Info

Cas No.

91396-88-2

Purity

≥98%

Formula

C12H11N3O

Formula Wt.

213.24

IUPAC Name

N'-Phenylisonicotinohydrazide

Synonym

NSC 14613, PluriSln 1, Isonicotinic Acid 2-Phenylhydrazide, Plurisin #1

Solubility

10mM in DMSO

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

P4782 MSDS PDF

Info Sheet

P4782 Info Sheet PDF

References

Zhang L, Pan Y, Qin G, et al. Inhibition of stearoyl-coA desaturase selectively eliminates tumorigenic Nanog-positive cells: improving the safety of iPS cell transplantation to myocardium. Cell Cycle. 2014;13(5):762-71. PMID: 24394703.

Ben-David U, Gan QF, Golan-Lev T, et al. Selective elimination of human pluripotent stem cells by an oleate synthesis inhibitor discovered in a high-throughput screen. Cell Stem Cell. 2013 Feb 7;12(2):167-79. PMID: 23318055.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • V9201

    VX-11e

    ERK2 inhibitor, potential AurKA, GSK3, CDK2, FLT3,...
    ≥98%
  • A5287

    Angiotensinogen (1-14), human

    Peptide fragment, renin substrate, precursor to AT...
    ≥95%
  • C1648

    α-Cembrenediol

    Diterpene found in Anisomeles.
    ≥99%
  • C0375

    Ac-DEVD-pNA

    Caspase 3 substrate.
    ≥95%
  • M1335

    Mdivi-1

    Quinazolinone; mitochondrial division inhibitor.
    ≥98%
  • T1016

    Propyl Analog of Pacitaxel

    Propyl Analog of Pacitaxel (taxcultine) is an impu...
    ≥95%
  • O6953

    Ornidazole

    5-Nitroimidazole derivative; genotoxic.
    ≥98%
  • P0344

    Palbociclib Isethionate

    CDK4/6 inhibitor.
    ≥98%
  • S1846

    Selumetinib

    MEK1/2 inhibitor.
    ≥98%
  • P2858

    4-α-Phorbol-12-myristate-13-acetate

    Negative control for PKC activation.
    ≥98%
  • B6811

    [Tyr8]-Bradykinin

    Natriuretic, vasodilatory peptide, bradykinin anal...
    ≥95%
  • I7870

    Itraconazole

    Triazole; 14-α demethylase inhibitor, Smo modulat...
    ≥98%
  • A5061

    Ampalex

    Benzylpiperidine; AMPA potentiator.
    ≥98%
  • A1371

    Adrenorphin

    Endogenous opioid peptide; μOR and κOR agonist.
    ≥95%
  • J6400

    (+)-JQ-1

    Triazolothienodiazepine; BRD inhibitor.
    ≥99%
  • K9200

    KX1-004

    Indole; Src inhibitor.
    ≥98%
  • P7000

    PR-619

    Deubiquitinating enzyme inhibitor.
    ≥98%
  • C0800

    C59

    PORCN inhibitor.
    ≥98%
  • A5477

    Antide Acetate

    GnRH antagonist.
    ≥95%
  • T1953

    Tenovin-3

    Potential p53 activator or SIRT2 inhibitor.
    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2026 LKT Laboratories, All Rights Reserved - Products for research use only